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Abstract
Sulforaphane is a naturally occurring isothiocyanate in cruciferous vegetables. Sulforaphane
inhibits histone deacetylases, leading to the transcriptional activation of genes including tumor
suppressor genes. The compound has attracted considerable attention in the chemoprevention of
prostate cancer. Here we tested the hypothesis that sulforaphane is not specific for tumor
suppressor genes but also activates loci such as long terminal repeats (LTRs), which might impair
genome stability. Studies were conducted using chemically pure sulforaphane in primary human
IMR-90 fibroblasts and in broccoli sprout feeding studies in healthy adults. Sulforaphane (2.0 μM)
caused an increase in LTR transcriptional activity in cultured cells. Consumption of broccoli
sprouts (34, 68, or 102g) by human volunteers caused a dose dependent elevation in LTR mRNA
in circulating leukocytes, peaking at more than a 10-fold increase. This increase in transcript
levels was associated with an increase in histone H3 K9 acetylation marks in LTR 15 in peripheral
blood mononuclear cells from subjects consuming sprouts. Collectively, this study suggests that
sulforaphane has off-target effects that warrant further investigation when recommending high
levels of sulforaphane intake, despite its promising activities in chemoprevention.
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1. Introduction
Cruciferous vegetables such as broccoli and cauliflower contain a large number of
glucosinolates including glucoerucin, glucoiberin, and glucoraphanin (1). When unheated
vegetables are processed by chopping or chewing, the enzyme myrosinase is released from
myrosin grains in myrosin cells and glucosinolates are released from adjacent S cells (2–4).
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Myrosinase catalyzes the hydrolytic removal of the glucose moiety in glucoraphanin,
followed by non-enzymatic release of a hydrogen sulfate moiety and spontaneous
rearrangement of the unstable intermediate to form the aliphatic isothiocyanate sulforaphane
(SFN) (1). SFN has attracted considerable attention due to its putative role in cancer
prevention (5).
Various, not mutually exclusive, mechanisms have been proposed to explain the
chemopreventive activities of SFN. One theory is that SFN enhances drug-mediated
cytotoxicity against cancer cells including cancer stem cells (6–8). The significance of these
observations is not limited to the chemotherapy of cancer but extends to the prevention of
cancer through enhancing cellular sensitivity to cell death signals in tumor initiation. SFN-
dependent inhibition of anti-apoptotic NF-κB signaling pathways appear to play a major role
in the elimination of abnormal cells (9, 10). A second theory is that SFN-dependent
inhibition of histone deacetylases (HDACs) causes an increase in the expression of tumor
suppressor genes such as p21 and Bax, leading to cell cycle arrest and apoptosis (11, 12).
Evidence suggests that SFN inhibits class I and class II HDACs (13). The locus (gene)
specificity of SFN is uncertain, despite a general consensus that chemoprevention needs to
pursue gene-specific gene expression through the modulation of epigenetic marks in distinct
genomic loci (14). Gene-specific epigenetic editing can, theoretically, be achieved by fusing
enzymes or inhibitors to gene-specific DNA binding domains.
In this paper we tested the hypothesis that the inhibition of HDACs by SFN does not only
de-repress tumor suppressor genes, but also has undesirable off-target effects, meditated be
de-repression of genes other than tumor suppressor genes. Studies were conducted in both
cell cultures and healthy adults to take advantage of the small inter-individual variation in
cell cultures and to capture effects of biotransformation in human studies. As model loci for
detecting off-target effects we used long-terminal repeats (LTRs), based on the following
rationale.
LTRs make up about 8% of the human genome and at least 51 LTRs are transcriptionally
competent (15). Repetitive elements such as LTRs pose a burden to genome stability, as
their mobilization facilitates recombination between non-homologous loci, leading to
chromosomal deletions and translocations (16, 17). Mobilization of LTR transposons is
associated with 10% of all spontaneous mutations in mice (18). The transcriptional activity
of LTRs is controlled by histone acetylation and other epigenetic marks; inhibition of
HDACs leads to an increase in LTR transcription (19). De-repression of LTRs may impair
genome stability through insertional mutagenesis, recombination events that cause
translocations and other rearrangements, deregulation of genes in the host genome mediated
by LTR promoter activity, and antisense effects if transcription extends into exon sequence
downstream of the transposon (20).
2. Methods and Materials
2.1. Cell cultures
Primary human IMR-90 lung fibroblasts from a female Caucasian were obtained from
American Type Culture Collection (ATCC CCL-186; Manassas, VA). IMR-90 fibroblasts
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are primary human cells that have not been transformed or immortalized in any way.
Therefore, the genetic make-up of IMR-90 fibroblasts is identical to that of human tissues,
leaving no room for uncertainties regarding possible impacts of altered genetics as
encountered in immortalized cell lines. Fibroblasts (from passages 32–36) were cultured in
Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum, 0.1%
sodium pyruvate, 100,000 U/L penicillin,100 mg/L streptomycin, and 0.1% non-essential
amino acids (final concentrations). R,S-SFN was obtained from LKT Laboratories (St. Paul,
MN) and was dissolved in DMSO to prepare a stock solution containing 40 mmol/l SFN.
Aliquots were frozen at −20°C until use. SFN concentrations in cell culture media were
adjusted to a final concentration of 2.0 μmol/l; controls were treated with solvent. Samples
were collected at timed intervals.
2.2. Human feeding study
Eight apparently healthy adults (4 male, 4 female) participated in a broccoli sprout feeding
study approved by the Institutional Review Board at the University of Nebraska-Lincoln.
Exclusion criteria included pregnancy, smoking, self-reported health problems, and use of
SFN supplements. Participants in this study included 6 Caucasians (2 Hispanics) and 2
Asians ages 19–30 years. Subjects were instructed not to consume cruciferous vegetables in
the 48 hours leading up to the study and during the eight-hour period in which blood
samples were collected. Each subject consumed three doses (34 g, 68 g, 102 g) of
BroccoSprouts® broccoli sprouts from a local supermarket (HyVee, Lincoln, NE). Sprouts
were consumed with a bagel and cream cheese (11). Each treatment was separated by a two
week washout period and the order of doses was randomized. Thirty milliliters of blood
were collected before sprout consumption (baseline, time 0 h) and at timed intervals (2, 4,
and 8 h) after consumption. Peripheral blood mononuclear cells (PBMC) and plasma were
purified using Histopaque and gradient centrifugation as described previously (21); aliquots
were frozen at −80°C until analysis.
2.3. Quantitation of SFN
SFN was extracted and quantitated by HPLC as previously described (22). Briefly, 1 g of
BroccoSprouts® was combined with 20 ml of water acidified with 0.1 M hydrochloric acid
and homogenized for 10–15 seconds with a Tissue-Tearor model 985370 hand-held
homogenizer (Biospec Products, Inc., Bartlesville, OK). Extracts were transferred to a 45°C
water bath for 2 hours and then cooled to room temperature. The solution was extracted
twice with 20 ml dichloromethane and the solvent phases were collected and combined. The
solvent was dried through sodium sulfate and then loaded onto a Supelclean™ LC-Florisil®
SPE column (Supelco). The column was washed with 3 ml ethyl acetate and SFN was
collected with 3 ml methanol. Samples were passed through a 0.2 μm filter and stored at
−20°C until analysis. Determination of SFN concentration was performed by injection on a
Waters (Milford, MA) 600S HPLC system equipped with a VyDac C18 (Grace, Deerfield,
IL) column and a Waters 2996 Photodiode Array detector. Separation was achieved with an
isocratic flow rate of 1.0 ml/min using water and acetonitrile (30:70 v/v). A sample volume
of 20 μl was injected.
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2.4. Quantitative Real-Time PCR (qRT-PCR)
The abundance of p21 mRNA and LTR mRNA (transcript R/U5) was quantified by qRT-
PCR as previously described using the cycle threshold method; glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used to normalize for PCR efficiency (23, 24). PCR primer
sequences for p21 were 5′-AGGCGGTTATGAAATTCACC-3′ (forward) and 5′-
CCCTTCAAAGTGCCATCTG-3′ (reverse). LTR primer sequences were the same as
previously reported (25). Note that the values for LTR mRNA represent the grand total of all
transcriptionally active LTRs due to near-identical sequences in these repeats (25). Areas
under the curves (AUCs) for LTR mRNA were calculated using the linear trapezoidal rule
and were corrected for baseline levels (26).
2.5. Chromatin Immunoprecipitation (ChIP) assays
ChIP assays were performed as previously described (23). Antibody against K9-acetylated
histone H3 (H3K9ac; ab10812) was purchased from Abcam (Cambridge, MA). Data were
normalized for nucleosomal occupancy using an antibody to the C-terminus in histone H3.
The enrichment of H3K9ac marks in LTR15 {nomenclature as per (15)} were quantified by
qRT-PCR, using GAPDH as a control. PCR primer sequences were the same as in our
previous studies (25). In case of ChIP assays, as opposed to mRNA quantification,
individual LTRs can be distinguished by having one PCR primer anneal with sequences in
the host genome adjacent to the LTR of interest.
2.6. Statistics
Homogeneity of variances was tested using Bartlett’s Test. If variances were heterogeneous,
data was log transformed before analysis. Data from IMR90 cell cultures were analyzed by
using the Wilcoxon Signed-Rank Test. Data from PBMC experiments were analyzed using
one-way analysis of variance (ANOVA) and Fisher’s LSD for posthoc comparisons (27) for
gene expression data and Wilcoxon Signed-Rank Test for ChIP data. Differences were
considered statistically significant if p<0.05. StatView 5.0.1 was used for conducting
statistical analyses (SAS Institute; Cary, NC).
3. Results
3.1. LTR transcript levels increase after SFN treatment in IMR-90 fibroblast cultures
SFN de-repressed LTRs in IMR-90 fibroblasts (Fig. 1). A significant increase in LTR
mRNA was detectable at t = 4 h, and peak values were achieved at t = 6 h compared with
vehicle controls. LTR expression levels returned to baseline levels after 16 h of SFN
treatment. The expression of the p21 tumor suppressor also increased in response to SFN
treatment (Fig. 2), consistent with previous reports in BPH-1, LnCaP, and PC-3 prostate
epithelial cells (28), but this increase in p21 mRNA was not statistically significant.
3.2. Human consumption of broccoli sprouts increases LTR expression and histone
acetylation
The expression of LTRs increased dose-dependently in response to consumption of broccoli
sprouts, as judged by the AUCs for LTR mRNA in PBMC (Fig. 3). The AUCs for LTR
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transcripts in subjects consuming 34 g, 68 g, and 102 g sprouts were 1.29 ± 2.38, 5.54 ±
5.26, and 13.06 ± 23.68 arbitrary units, respectively, compared with baseline. The increase
was significantly greater for the 68 g and 102 g doses compared with the 34 g dose (p<0.05,
N=8). The AUCs for p21 mRNA in subjects consuming 34 g, 68 g, and 102 g sprouts were
0.80 ± 1.43, 0.73 ± 0.90, 2.46 ± 3.00 arbitrary units, respectively, compared with baseline;
however the differences were not statistically significant (p>0.05, N=8). Note that the level
of SFN in Broccosprouts® was 18 mg/g fresh weight.
The de-repression of LTRs was associated with an increased abundance of H3K9ac marks in
LTR15 at t = 4 h compared with t = 0 h (Fig. 4A). The magnitude of the effect depended on
the amount of broccoli sprouts that was consumed; meaningful increases in H3K9ac
enrichment at t = 4 h were observed when sprout doses exceeded 34 g (Fig. 4B).
4. Discussion
To the best of our knowledge, this is the first report suggesting possible off target effects of
SFN in the de-repression of LTRs in both primary cells and human feeding studies. The
increase in LTR mRNA abundance was not only statistically significant but also appears to
be of biological importance, considering that the AUC for LTR mRNA increased by more
than 10 times for the highest dose of broccoli sprouts. The doses tested in cell cultures and
feeding studies are nutritionally relevant as levels of SFN tested in cell culture were based
on previous results in human feeding studies (29). Our observations were corroborated by an
increase in the abundance of H3K9ac marks in LTRs, consistent with their de-repression.
Note that SFN also increased the expression of the tumor suppressor gene p21, albeit to a
smaller extent than previously reported (30). The comparably small increase in p21
expression in response to SFN might be due to us using nutritionally meaningful levels,
whereas other studies typically concentrations of at least 15 μmol/l SFN (9, 31–33).
Our observations are important for human health, considering the roles of LTRs in impairing
genome stability (see Introduction) and the widespread availability of SFN-containing foods
and supplements. The sprouts used in this study, Broccosprouts®, are widely available in the
United States; the lowest dose that was tested, 34 g, is about one serving according to
product labeling. One serving of broccoli sprouts may contain levels of SFN sufficient to de-
repress LTRs. SFN-containing supplements are also available to consumers over the
counter. To the best of our knowledge, there are no data available for the consumption of
SFN supplements in the United States, but supplement use in general is fairly common. For
example, approximately 50% of all Americans and 64–81%, of cancer survivors take
nutritional supplements (34). Of the many SFN supplements on the market, wide ranges of
doses are available. One product, BroccoMax® is a supplement labeled as having 30 mg
sulforaphane glucosinolate per serving, providing a dose of SFN similar to the dose tested in
this study. One could assume with a reasonable level of confidence that consuming such
doses of SFN on a regular basis could elicit effects exceeding those seen in this study where
single doses were administered. Note that we do not dispute the potential benefits of SFN in
the chemoprevention of cancer (6–8, 11, 12). However, we propose that SFN needs to be
considered in the context of gene-specific editing (14).
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There are some uncertainties that need to be addressed in future studies. First, the effects of
SFN on the de-repression of LTRs (and p21) are transient, and it remains to be determined
whether a de-repression that last a few hours is sufficient to elicit biologically meaningful
effects. Second, while the de-repression of LTRs was quantitatively important, it remains to
be seen whether the observed increase in LTR expression is sufficient to impair genome
stability.
Collectively, this study suggests that sulforaphane has off-target effects that warrant further
investigation when recommending high levels of sulforaphane intake, despite its promising
activities in chemoprevention.
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SFN increases LTR transcription in IMR-90 fibroblast cultures. Fibroblasts were treated
with 2.0 μmol/l SFN (squares) or solvent (triangles). *Significantly different compared with
vehicle control at the same collection time (p<0.05 by Wilcoxon Signed-Rank test, N=4–7).
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SFN had no significant effect on p21 transcription in IMR-90 fibroblast cultures. Fibroblasts
were treated with 2.0 μmol/l SFN (squares) or solvent (triangles). *Significantly different
compared with vehicle control at the same collection time (p<0.05 by Wilcoxon Signed-
Rank test, N=4–7).
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AUC for LTR (black bars) and p21 (gray bars) expression increases in a dose-dependent
manner following three broccoli sprout doses in healthy adults. Statistical significance
determined by ANOVA with Fisher’s LSD used for posthoc comparisons. a,bColumns not
sharing the same letters are significantly different for the same treatment group (SFN vs.
control; p<0.05, N=8).
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(A) Broccoli sprout consumption increases enrichment of H3K9ac mark in LTR15 in
PBMCs from human subjects consuming 102 g broccoli sprouts. *Significantly different
than controls as per Wilcoxon Signed-Rank test (p<0.05, N=8). (B) Dose-response curve for
the H3K9ac mark in LTR15 in PBMCs from a representative subject.
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